Immunotherapy for Cancer - NCI - National Cancer Institute
Sep 24, 2019 · Researchers are testing combinations of immune checkpoint inhibitors and other types of immunotherapy, targeted therapy, and radiation therapy to overcome resistance to immunotherapy. Finding ways to predict responses to immunotherapy.
Therapeutic targets and biomarkers of tumor immunotherapy: …
Sep 19, 2022 · In this article, we describe the efforts to manipulate the immune system against cancer and discuss different targets and cell types that can be exploited to promote the antitumor immune...
The future of cancer immunotherapy: microenvironment …
May 28, 2020 · In addressing frontiers in clinical immunotherapy, we describe two categories of approaches to the design of novel drugs and combination therapies: the first involves direct modification of the...
Targeted Therapy for Cancer - NCI - National Cancer Institute
May 31, 2022 · Targeted therapy treats cancer by targeting proteins that control how cancer cells grow, divide, and spread. What is targeted therapy? What are the types of targeted therapy? Who is treated with targeted therapy? How does targeted therapy work against cancer? Are there drawbacks to targeted therapy? What are the side effects of targeted therapy?
New immunotherapy platform could increase potential to target …
1 day ago · Immunotherapy presents a promising strategy for treating cancer, autoimmune diseases, and viral infections, but its effectiveness depends on its ability to target diseases cells.
A guide to cancer immunotherapy: from T cell basic science to …
May 20, 2020 · In this Review, we emphasize the role of T cells in modern cancer immunotherapies and discuss three different categories of immunotherapeutic approaches to treat cancer: immune checkpoint...
Therapeutic targets and biomarkers of tumor immunotherapy: …
Sep 19, 2022 · Among them, immune checkpoint blocking therapy, represented by PD-1/PD-L1 inhibitors (nivolumab) and CTLA-4 inhibitors (ipilimumab), has shown encouraging therapeutic effects in the treatment of various malignant tumors, …
Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined …
Mar 21, 2024 · Immune checkpoint therapy, which targets regulatory pathways in T cells to enhance anti-tumor immune responses, has led to important clinical advances and provided a new weapon against cancer.
Exploring Shared Targets in Cancer Immunotherapy and Cancer …
4 days ago · Emerging preclinical evidence suggests that targets related to tumor immunotherapy may also modulate cancer-related pain pathways, thus offering a promising therapeutic direction. This review, focusing on more than ten molecular targets that link cancer immunotherapy and cancer-induced bone pain, underscores their potential to tackle both ...
Immunotherapy and targeted therapy—the new roadmap in …
The search goes on for potential immunotherapy targets, resistance mechanisms and how to further enhance their responses. More and more cancer types which were previously considered non-immunogenic with limited role of immunotherapy are now showing signs of change.
- Some results have been removed